{"id":"W4381336619","doi":"10.1093/bjd/ljad162.036","title":"416 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Regimen; Concomitant; Adverse effect; Dermatology; Internal medicine; Clinical endpoint; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00299573,0.0008605255,0.001862774,0.0002695136,0.0005955833,0.001019683,0.0004294307,0.001470064,0.003052079],"category_scores_gemma":[0.001506071,0.0003543769,0.002672976,0.0003342904,0.0007468555,0.001001611,0.0004162131,0.002224204,0.000849688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005845179,"about_ca_system_score_gemma":0.0009259445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000462513,"about_ca_topic_score_gemma":0.001301876,"domain_scores_codex":[0.9988905,0.000445777,0.0001292864,0.0001893616,0.0001296561,0.0002154017],"domain_scores_gemma":[0.9984637,0.0002896243,0.0003917828,0.0001560963,0.0001998974,0.0004989291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8833354,0.03469584,0.009924949,0.001242292,0.002561148,0.0002141733,0.0002520904,0.0004330512,0.01441695,0.0001141171,0.001660376,0.0511496],"study_design_scores_gemma":[0.3397879,0.6071874,0.04339782,0.0001393066,0.002394747,0.0002573972,0.0001178923,0.0005165977,0.002272007,0.000161188,0.003718126,0.00004950074],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904389,0.005219649,0.0002527768,0.0002246209,0.000153935,0.001388432,0.001052353,0.00003533337,0.001234081],"genre_scores_gemma":[0.991789,0.001871199,0.00068178,0.0007598528,0.0003014244,0.001511283,0.0016984,0.000009189029,0.001377848],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003052079,"threshold_uncertainty_score":0.01584309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0289953219994888,"score_gpt":0.3160345474933585,"score_spread":0.2870392254938697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}